Understanding the pathophysiology of itch

Dermatologic Therapy

Volumn 26, Issue 2, 2013, Pages 84-91

  Garibyan, Lilit ^a   Rheingold, Curtis G ^a   Lerner, Ethan A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

itch; mediator; neuron; pruritus

Indexed keywords

CATION CHANNEL; CYTOKINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; INTERLEUKIN 31; SUBSTANCE P; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TRANSIENT RECEPTOR POTENTIAL VANILLOID RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; INFLAMMATION; INTERNEURON; KERATINOCYTE; MOLECULAR PATHOLOGY; NERVE FIBER; NEUROANATOMY; NEUROPATHY; NOCICEPTION; NONHUMAN; NOTALGIA PARESTHETICA; PAIN; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; PRURITOCEPTION; PRURITUS; PSYCHOGENESIS; RISK FACTOR; SENSORY DYSFUNCTION; SENSORY NEUROPATHY;

HUMANS; PRURITUS; QUALITY OF LIFE; SKIN DISEASES;

EID: 84875857935     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12025     Document Type: Article

References (59)

1. Kini SP, DeLong LK, Veledar, E, McKenzie-Brown AM, Schaufele M, Chen SC,. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 2011: 147 (10): 1153-1156.
2. Yosipovitch G, Greaves MW, Schmelz M,. Itch. Lancet 2003: 361 (9358): 690-694.
3. Greaves MW,. Pathogenesis and treatment of pruritus. Curr Allergy Asthma Rep 2010: 10 (4): 236-242.
4. Yosipovitch G, Samuel LS,. Neuropathic and psychogenic itch. Dermatol Ther 2008: 21 (1): 32-41.
5. Krishnan A, Koo J,. Psyche, opioids, and itch: therapeutic consequences. Dermatol Ther 2005: 18 (4): 314-322.
6. Arnold LM, Auchenbach MB, McElroy SL,. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001: 15 (5): 351-359.
7. Gupta MA, Gupta AK, Ellis CN, Koblenzer CS,. Psychiatric evaluation of the dermatology patient. Dermatol Clin 2005: 23 (4): 591-599.
8. Koblenzer CS,. Cutaneous manifestations of psychiatric disease that commonly present to the dermatologist-diagnosis and treatment. Int J Psychiatry Med 1992: 22 (1): 47-63.
9. Oaklander AL,. Common neuropathic itch syndromes. Acta Derm Venereol 2012: 92 (2): 118-125.
10. Oaklander AL, Cohen S, Raju SV,. Intractable postherpetic itch and cutaneous deafferentation after facial shingles. Pain 2002: 96 (1-2): 9-12.
11. Oaklander AL, Romans K, Horasek S, Stocks A, Hauer P, Meyer RA,. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol 1998: 44 (5): 789-795.
12. Rowbotham MC, Yosipovitch G, Connolly MK, Finlay D, Forde G, Fields HL,. Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 1996: 3 (3): 205-214.
13. Savk E, Dikicioǧlu E, Culhaci N, Karaman G, Sendur N,. Immunohistochemical findings in notalgia paresthetica. Dermatology 2002: 204 (2): 88-93.
14. Springall DR, Karanth SS, Kirkham N, Darley CR, Polak JM,. Symptoms of notalgia paresthetica may be explained by increased dermal innervation. J Invest Dermatol 1991: 97 (3): 555-561.
15. Wallengren J, Sundler F,. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during the symptom-free remissions. J Am Acad Dermatol 2005: 52 (1): 142-145.
16. Cohen AD, Masalha R, Medvedovsky E, Vardy DA,. Brachioradial pruritus: a symptom of neuropathy. J Am Acad Dermatol 2003: 48 (6): 825-828.
17. Goodkin R, Wingard E, Bernhard JD,. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic [corrected] pruritus. J Am Acad Dermatol 2003: 48 (4): 521-524.
18. Yosipovitch G,. Assessment of itch: more to be learned and improvements to be made. J Invest Dermatol 2003: 121 (6): xiv-xxv.
19. Lawson SN,. Phenotype and function of somatic primary afferent nociceptive neurones with C-, Adelta- or Aalpha/beta-fibres. Exp Physiol 2002: 87 (2): 239-244.
20. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE,. Specific C-receptors for itch in human skin. J Neurosci 1997: 17 (20): 8003-8008.
21. Yosipovitch G, Fleischer A,. Itch associated with skin disease: advances in pathophysiology and emerging therapies. Am J Clin Dermatol 2003: 4 (9): 617-622.
22. Han L, Ma C, Liu Q, Weng HJ, Cui Y, Tang Z, Kim Y, Nie H, Qu L, Patel KN, Li Z, McNeil B, He S, Guan Y, Xiao B, Lamotte RH, Dong X,. A subpopulation of nociceptors specifically linked to itch. Nat Neurosci 2012: 16: 174-182.
23. Handwerker HO,. Microneurography of pruritus. Neurosci Lett 2010: 470 (3): 193-196.
24. Napadow V, Li A, Loggia ML, Kim J, Schalock PC, Lerner E, Tran TN, Ring J, Rosen BR, Kaptchuk TJ, Pfab F,. The brain circuitry mediating antipruritic effects of acupuncture. Cerebral Cortex 2013. Epub ahead of print.
25. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M,. The neurobiology of itch. Nat Rev Neurosci 2006: 7 (7): 535-547.
26. Patel KN, Dong X,. Itch: cells, molecules, and circuits. ACS Chem Neurosci 2011: 2 (1): 17-25.
27. Ikoma A, Rukwied R, Ständer S, Steinhoff M, Miyachi Y, Schmelz M,. Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol 2003: 139 (11): 1475-1478.
28. Klein PA, Clark RA,. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999: 135 (12): 1522-1525.
29. Jutel M, Akdis M, Akdis CA,. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009: 39 (12): 1786-1800.
30. de Esch IJ, Thurmond RL, Jongejan A, Leurs R,. The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 2005: 26 (9): 462-469.
31. Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL,. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 2006: 176 (11): 7062-7070.
32. Bell JK, McQueen DS, Rees JL,. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 2004: 142 (2): 374-380.
33. Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL,. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007: 119 (1): 176-183.
34. Shelley WB, Arthur R,. The neurohistology and neurophysiology of the itch sensation in man. AMA Arch Dermatol 1957: 76 (3): 296-323.
35. Järvikallio A, Naukkarinen A, Harvima IT, Aalto ML, Horsmanheimo M,. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997: 136 (6): 871-877.
36. Reddy VB, Iuga AO, Shimada SG, LaMotte RH, Lerner EA,. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci 2008: 28 (17): 4331-4335.
37. Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003: 23 (15): 6176-6180.
38. Steinhoff M, Vergnolle N, Young SH, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000: 6 (2): 151-158.
39. Hägermark O,. Itch mediators. Semin Dermatol 1995: 14 (4): 271-276.
40. Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, Petersen LJ, Schmelz M,. Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study. J Invest Dermatol 2000: 115 (6): 1015-1020.
41. Szallasi A, Blumberg PM,. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999: 51 (2): 159-212.
42. Morita A, Iwasaki Y, Kobata K, Iida T, Higashi T, Oda K, Suzuki A, Narukawa M, Sasakuma S, Yokogoshi H, Yazawa S, Tominaga M, Watanabe T,. Lipophilicity of capsaicinoids and capsinoids influences the multiple activation process of rat TRPV1. Life Sci 2006: 79 (24): 2303-2310.
43. Stander S, Moormann C, Schumacher M, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004: 13 (3): 129-139.
44. Bodõ E, Kovács I, Telek A, Varga A, Paus R, Kovács L, Bírõ T,. Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol 2004: 123 (2): 410-413.
45. Denda M, Fuziwara S, Inoue K, Denda S, Akamatsu H, Tomitaka A, Matsunaga K,. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 2001: 285 (5): 1250-1252.
46. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D,. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997: 389 (6653): 816-824.
47. Shim WS, Tak MH, Lee MH, Kim M, Kim M, Koo JY, Lee CH, Kim M, Oh U,. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 2007: 27 (9): 2331-2337.
48. Imamachi N, Park GH, Lee H, Anderson DJ, Simon MI, Basbaum AI, Han SK,. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A 2009: 106 (27): 11330-11335.
49. Gooding SM, Canter PH, Coelho HF, Boddy K, Ernst E,. Systematic review of topical capsaicin in the treatment of pruritus. Int J Dermatol 2010: 49 (8): 858-865.
50. Ross SE,. Pain and itch: insights into the neural circuits of aversive somatosensation in health and disease. Curr Opin Neurobiol 2011: 21 (6): 880-887.
51. Bromm B, Scharein E, Darsow U, Ring J,. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 1995: 187 (3): 157-160.
52. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B,. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006: 117 (2): 411-417.
53. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA,. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004: 5 (7): 752-760.
54. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA,. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol 2009: 161 (6): 1217-1224.
55. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Grønhøj-Larsen C, Matsushima K,. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009: 18 (1): 35-43.
56. Amatya B, Nordlind K, Wahlgren CF,. Responses to intradermal injections of substance P in psoriasis patients with pruritus. Skin Pharmacol Physiol 2010: 23 (3): 133-138.
57. Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martín JD, Candenas ML,. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 2004: 11 (15): 2045-2081.
58. Carstens EE, Carstens MI, Simons CT, Jinks SL,. Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats. Neuroreport 2010: 21 (4): 303-308.
59. Chang SE, Han SS, Jung HJ, Choi JH,. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 2007: 156 (6): 1272-1277.